Why the study?
Early hemodynamic changes are associated with in-hospital outcomes in cardiogenic shock, but evidence on comprehensive non-invasive hemodynamic assessment by echocardiography at presentation and 48 hours was limited.
Does longitudinal non-invasive hemodynamic assessment by echocardiography at baseline and 48 hours predict in-hospital mortality, LVAD implantation, or heart transplantation in patients with cardiogenic shock?
Cohort (n=457)
Yes
Does longitudinal non-invasive hemodynamic assessment by echocardiography at baseline and 48 hours predict in-hospital mortality, LVAD implantation, or heart transplantation in patients with cardiogenic shock?
Serial non-invasive echocardiographic hemodynamic assessment over the first 48 hours in cardiogenic shock effectively stratifies risk, with persistently low cardiac power output and elevated filling and pulmonary pressures independently predicting in-hospital death, LVAD, or heart transplantation.
Answers are grounded in this paper and cite their sources.
May support serial echo for risk stratification in cardiogenic shock; extends observational associations but leaves open prospective validation.
BACKGROUND: In cardiogenic shock (CS), early hemodynamic changes are associated with in-hospital outcomes, but evidence on non-invasive assessment is limited. We evaluated the prognostic value of a comprehensive non-invasive hemodynamic assessment by echocardiography ("echo-dynamics") at presentation and 48 hours in CS. METHODS: Consecutive CS patients at four Cardiac Intensive Care Units were prospectively enrolled. Echo-dynamics were obtained at baseline and 48 hours, including stroke volume index (SVi), cardiac index (CI), cardiac power output (CPO), estimated left atrial pressure (E/e'), systolic pulmonary arterial pressure (eSPAP) and right atrial pressure. The primary outcome was a composite of in-hospital mortality, left ventricular assist device implantation or heart transplantation. RESULTS: Among 457 patients (37.9% acute myocardial infarction-CS, 42.9% SCAI CS stage ≥C, 28% mean ejection fraction), the primary outcome occurred in 30.0%. Each echo-dynamic parameter was associated with the outcome at both time points after adjustment for age, sex, CS etiology and severity. Changes from baseline to 48 hours showed a stepwise risk increase across improving, worsening, or persistently abnormal trajectories (p-trend<0.01). In fully adjusted models, baseline CPO<0.6 W (adj-OR 2.05, 95%CI 1.29-3.26) and eSPAP ≥35 mmHg (adj-OR 2.45, 95%CI 1.44-4.15) were associated with outcomes; at 48 hours, CPO<0.6 W (adj-OR 2.70, 95%CI 1.57-4.66), increased E/e' (adj-OR 1.86, 95%CI 1.09-3.15) and eSPAP ≥35 mmHg (adj-OR 1.90, 95%CI 1.12-3.22) remained independently associated. Results were consistent when adjusting for SCAI stage. CONCLUSIONS: In CS, longitudinal echo-dynamic assessment identifies distinct trajectories with prognostic implications. Persistently low cardiac power, and elevated filling and pulmonary pressures showed the strongest association with adverse outcomes.
No takes yet. Share an insight, caveat, or question.
Gallone et al. (2026) conducted a cohort in Cardiogenic shock (n=457). Longitudinal non-invasive echocardiographic hemodynamic assessment (echo-dynamics) was evaluated on Composite of in-hospital mortality, left ventricular assist device implantation, or heart transplantation (OR 2.70, 95% CI 1.57-4.66, p=<0.01).
Synapse has enriched 10 related papers. Consider them for comparative context: